Fermer le menu


Member of Lyonbiopole


AIOVA is an emerging biotech company focusing on the development of innovative DNA vaccines with unmatched performance to fight against emergent or re-emergent infectious diseases such as HIV/AIDS, Influenza/Flu and now against the coronaviruses/COVID (SARS-CoV-2 and its variants). AIOVA DNA vaccines are cost-effective and have unique properties conferring an “enhanced” vaccination. Injecting the DNA vaccine in the host induces a protective and long-lasting immunity (several years) and a protection against the original virus and its variants (so-called pan or universal vaccines).


Strategic application domain: Human Medicine

Application market: Infectious Diseases

Type of activity: Therapeutics, Pharma or Biotech

Technologies: Molecular Biology & Nucleic acid, Vaccine

Created on may 28th, 2020 - 1 employees



Université Grenoble-Alpes. Bât Nanobio. 570 rue de la Chimie. 38400 Saint Martin d'Hères



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.